Key Stakeholders: PPM (program and portfolio management), ASL (Asset strategy leadership), Pipeline Commercialization, Clinical Development, Regulatory, R&D Finance, Commercial Finance, R&D Strategic Resourcing, Commercial Business Units, Search & Evaluation, Business Development, Innovation, Transformation, Statistics, TA Strategy. Build value metrics (e.g., raNPV, PI) and any required scenario analysis to drive effective drug development decisions, working with ASLs (asset strategy leaders), Search & Evaluation (S&E), program managers, pipeline commercial leads, forecasting teams and others.